Tag:
levomilnacipran
Latest Headlines
Latest Headlines
Positive Phase III sets stage for levomilnacipran NDA
Investigators at Forest Laboratories ( $FRX ) and Pierre Fabre Medicament say they're on track to file an NDA for the anti-depression drug levomilnacipran.
Forest Labs antidepressant flunks Phase III hurdle
Forest Laboratories and Pierre Fabre Medicament say that one of their three late-stage studies for the antidepressant levomilnacipran failed to hit its primary endpoint. "Although the overall
